These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29042091)

  • 1. Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial.
    Engholm M; Bertelsen JB; Mathiassen ON; Bøtker HE; Vase H; Peters CD; Bech JN; Buus NH; Schroeder AP; Rickers H; Hansen KW; Poulsen PL; Kaltoft A; Christensen KL
    Int J Cardiol; 2018 Jan; 250():29-34. PubMed ID: 29042091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON; Vase H; Bech JN; Christensen KL; Buus NH; Schroeder AP; Lederballe O; Rickers H; Kampmann U; Poulsen PL; Hansen KW; Btker HE; Peters CD; Engholm M; Bertelsen JB; Lassen JF; Langfeldt S; Andersen G; Pedersen EB; Kaltoft A
    J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial).
    Peters CD; Mathiassen ON; Vase H; Bech Nørgaard J; Christensen KL; Schroeder AP; Rickers HJVH; Opstrup UK; Poulsen PL; Langfeldt S; Andersen G; Hansen KW; Bøtker HE; Engholm M; Bertelsen JB; Pedersen EB; Kaltoft A; Buus NH
    Blood Press; 2017 Dec; 26(6):366-380. PubMed ID: 28830251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in blood pressure and systemic vascular resistance do not predict microvascular structure during treatment of mild essential hypertension.
    Eftekhari A; Mathiassen ON; Buus NH; Gotzsche O; Mulvany MJ; Christensen KL
    J Hypertens; 2012 Apr; 30(4):794-801. PubMed ID: 22306851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of renal denervation on coronary flow reserve in patients with resistant hypertension.
    Völz S; Andersson B; Ljungman C; Gan LM; Rundqvist B; Svedlund S
    Clin Physiol Funct Imaging; 2019 Jan; 39(1):15-21. PubMed ID: 29761608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients.
    Engholm M; Mulvany MJ; Eftekhari A; Mathiassen ON; Buus NH; Christensen KL
    J Hum Hypertens; 2016 Nov; 30(11):690-696. PubMed ID: 26961172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging.
    Schmid A; Schmieder R; Lell M; Janka R; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):426-32. PubMed ID: 26253780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients.
    Ott C; Harazny JM; Schmid A; Ditting T; Veelken R; Bladowski M; Michelson G; Uder M; Schmieder RE
    Clin Res Cardiol; 2015 Sep; 104(9):782-9. PubMed ID: 25916737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Stroke Volume After Renal Denervation: Insight From Cardiac Magnetic Resonance Imaging.
    Lurz P; Kresoja KP; Rommel KP; von Roeder M; Besler C; Lücke C; Gutberlet M; Schmieder RE; Mahfoud F; Thiele H; Desch S; Fengler K
    Hypertension; 2020 Mar; 75(3):707-713. PubMed ID: 32008429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial and forearm blood flow reserve in mild-moderate essential hypertensive patients.
    Pedrinelli R; Dell'Omo G; Gimelli A; Di Bello V; Talarico L; Corchia A; Sambuceti G; Neglia D; Parodi O
    J Hypertens; 1997 Jun; 15(6):667-73. PubMed ID: 9218187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Böhm M; Mahfoud F; Townsend RR; Kandzari DE; Pocock S; Ukena C; Weber MA; Hoshide S; Patel M; Tyson CC; Weil J; Agdirlioglu T; Fahy M; Kario K
    Eur Heart J; 2019 Mar; 40(9):743-751. PubMed ID: 30608521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis.
    Fadl Elmula FEM; Feng YM; Jacobs L; Larstorp AC; Kjeldsen SE; Persu A; Staessen JA;
    Blood Press; 2017 Aug; 26(4):195-203. PubMed ID: 28443356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension.
    Bergo KK; Larstorp AC; Hoffmann P; Hjørnholm U; Cataliotti A; Høieggen A; Rostrup M; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):31-40. PubMed ID: 32633141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
    Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disproportionally impaired microvascular structure in essential hypertension.
    Eftekhari A; Mathiassen ON; Buus NH; Gotzsche O; Mulvany MJ; Christensen KL
    J Hypertens; 2011 May; 29(5):896-905. PubMed ID: 21330935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation in patients with resistant hypertension: six-month results.
    Dores H; de Sousa Almeida M; de Araújo Gonçalves P; Branco P; Gaspar A; Sousa H; Canha Gomes A; Andrade MJ; Carvalho MS; Campante Teles R; Raposo L; Mesquita Gabriel H; Pereira Machado F; Mendes M
    Rev Port Cardiol; 2014 Apr; 33(4):197-204. PubMed ID: 24472425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.
    Mahfoud F; Urban D; Teller D; Linz D; Stawowy P; Hassel JH; Fries P; Dreysse S; Wellnhofer E; Schneider G; Buecker A; Schneeweis C; Doltra A; Schlaich MP; Esler MD; Fleck E; Böhm M; Kelle S
    Eur Heart J; 2014 Sep; 35(33):2224-31b. PubMed ID: 24603307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.